Moderna, Inc. (MRNA)

Moderna Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-4,714	8,362	12,202	-747	-514
Depreciation & Amortization	621	348	232	93	31
Share-Based Compensation	305	226	142	93	81
Other Operating Activities	670	-3,955	1,044	2,588	-57
Operating Cash Flow	-3,118	4,981	13,620	2,027	-459
Operating Cash Flow Growth	-	-63.43%	571.93%	-	-
Capital Expenditures	-707	-400	-284	-68	-32
Acquisitions	-85	0	0	0	0
Change in Investments	4,998	-4,776	-8,239	-1,604	17
Investing Cash Flow	4,206	-5,176	-8,523	-1,672	-15
Share Issuance / Repurchase	-1,107	-3,264	-733	2,039	51
Debt Issued / Paid	-270	-184	-140	-6	1
Financing Cash Flow	-1,377	-3,448	-873	2,033	52
Net Cash Flow	-289	-3,643	4,224	2,388	-422
Free Cash Flow	-3,825	4,581	13,336	1,959	-491
Free Cash Flow Growth	-	-65.65%	580.76%	-	-
Free Cash Flow Margin	-55.86%	23.78%	72.20%	243.96%	-818.33%
Free Cash Flow Per Share	-10.01	11.63	33.09	5.14	-1.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).